Accelerate Diagnostics announces offering of 4.5M units

Accelerate Diagnostics announced the launch of a proposed underwritten public offering of 4.5M units, each consisting of one share of common stock and one warrant to purchase one share of common stock, or for certain investors, pre-funded units in lieu thereof, with each pre-funded unit consisting of one-pre-funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock, pursuant to a registration statement on Form S-1 filed with the U.S. SEC. William Blair & Company is acting as the sole book-running manager for the offering and Craig-Hallum Capital Group is acting as co-manager for the offering.